Reason for request
Extension of indication
Clinical Benefit
| Substantial |
The actual benefit of BERINERT is substantial in th is extension of the indication to the short-term pre-procedure prevention of acute HAE episodes. |
Clinical Added Value
| no clinical added value |
For the short-term pre-procedure prevention of acute HAE episodes, BERINERT does not provide any improvement in actual benefit (IAB V, non-existent) over other treatments already available. |
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
T7xFACUh02jV4u41
